Analysis of SHIP2 Expression and its Correlation with VEGF and HER-2 Expression in Breast Cancer
Received Date: Jun 11, 2017 / Accepted Date: Jul 13, 2017 / Published Date: Jul 17, 2017
Abstract
Purpose: To investigate SHIP2 expression in breast cancer tissues, and its correlation with clinicopathological features and with the expressions of VEGF and HER-2 in cancer tissues.
Methods: Immunohistochemical staining for SHIP2, HER-2 and VEGF was performed on paraffin-embedded tissue specimens, including 80 specimens of breast cancer and 53 adjacent tissue samples. Two pathologists were invited to interpret the immunohistochemistry results using double-blind method. Expression profiles of SHIP2, HER-2 and VEGF were evaluated and scored according to percentage of positive cells and positive signal intensity. The correlation between SHIP2 and clinicopathological features was analyzed by chi-square test and fourfold table exact test. The correlation among SHIP2, HER-2 and VEGF expression were analyzed using Pearson contingency coefficient analysis for evaluating prognostic relevance to breast cancer.
Results: The positive expression rates of SHIP2, HER-2 and VEGF were significantly higher than that of adjacent normal tissues (p<0.05). SHIP2 expression was significantly increased, in the case of the four risk factors (the poor histological grade, the later stages, lymph node metastasis, and higher BMI) (p<0.05). Positive rate of both SHIP2 and VEGF protein expression indicated a significant correlation between the two proteins (r=0.30, p<0.05). In addition, in the HER-2 protein positive group, SHIP2 protein expression also showed a positive correlation (r=0.71, p<0.05) between these two proteins. Expression of all three proteins were highly related to tumor histopathologic grade, clinical terms, and lymphatic metastasis (p<0.05). Our data indicates that SHIP2 expression in tumor tissue is significantly correlated with HER-2 and VEGF expression.
Conclusion: Our study provides a proof of concept that SHIP2, correlated with HER-2 and VEGF, plays important roles in tumorigenesis, infiltration, and metastasis of breast cancer, and are highly associated with prognosis.
Keywords: Breast cancer; HER-2; Immunohistochemistry; SHIP2; VEGF
Citation: Han H, Wang B, Zhao J, Xu G, Wang X, et al. (2017) Analysis of SHIP2 Expression and its Correlation with VEGF and HER-2 Expression in Breast Cancer. J Clin Exp Pathol 7:314. Doi: 10.4172/2161-0681.1000314
Copyright: © 2017 Han H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 3450
- [From(publication date): 0-2017 - Dec 23, 2024]
- Breakdown by view type
- HTML page views: 2779
- PDF downloads: 671
